These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16499507)

  • 1. How much can treatment reduce national drug problems?
    Reuter P; Pollack H
    Addiction; 2006 Mar; 101(3):341-7. PubMed ID: 16499507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting goals for drug policy: harm reduction or use reduction?
    Caulkins JP; Reuter P
    Addiction; 1997 Sep; 92(9):1143-50. PubMed ID: 9374012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is alcohol just another drug? Some thoughts on research and policy.
    Cook PJ; Reuter P
    Addiction; 2007 Aug; 102(8):1183-8. PubMed ID: 17624970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based interventions and alcohol, tobacco and other drugs: foci, outcomes and implications.
    Giesbrecht N; Haydon E
    Drug Alcohol Rev; 2006 Nov; 25(6):633-46. PubMed ID: 17132579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and treatment measures to reduce drug abuse: summary of responses to a survey of national programmes. United Nations Secretariat.
    Bull Narc; 1983; 35(3):33-40. PubMed ID: 6561043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of law enforcement in minimizing the harm resulting from illicit drugs.
    Hellawell K
    Drug Alcohol Rev; 1995; 14(3):317-22. PubMed ID: 16203327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug control strategies of United States law enforcement.
    Williams H
    Bull Narc; 1990; 42(1):27-39. PubMed ID: 2095933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years after the United Nations General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposals.
    Reuter P
    Addiction; 2009 Apr; 104(4):510-7. PubMed ID: 19335650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What drug policies cost: drug policy spending in the Netherlands in 2003.
    Rigter H
    Addiction; 2006 Mar; 101(3):323-9. PubMed ID: 16499504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canada's new federal 'National Anti-Drug Strategy': an informal audit of reported funding allocation.
    Debeck K; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2009 Mar; 20(2):188-91. PubMed ID: 18571396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilemmas in harm minimization.
    Weatherburn D
    Addiction; 2009 Mar; 104(3):335-9. PubMed ID: 18855811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.
    Rupp K; Strand A; Davies P; Sears J
    Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.